VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
URGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
URGNUroGen Pharma Ltd.
$36.98$1.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksURGNPrice History

URGN logoUroGen Pharma Ltd. (URGN) Stock Price History

Historical prices from 2017 to 2026

$36.83-0.15  (-0.41%)close Oct 9
Returns
1M
-15.6%
3M
-2.8%
YTD
+62.8%
1Y
+113.4%
3Y
+40.3%
5Y
+18.4%
ATH$69.57May 2018-47.1%
ATL$3.42May 2025pre-split
Avg Vol (50D)917K/ day
52-Week Range$15.86 — $50.81
LowCurrent: $36.83High

Loading 10-year price history...

URGN Historical Performance

1 YearTotal Return
+113.4%
Price: +113.4%
3 YearsTotal Return
+176.4%
CAGR: +40.3%
Price: +176.4%
5 YearsTotal Return
+132.9%
CAGR: +18.4%
Price: +132.9%
YTD
+62.8%

URGN Annual Returns

Year-by-year price performance · 2017–2026

Best+166.2%2017
Worst-47.1%2021
Up years5/10
2017+166.2%
2018+11.4%
2019-25.0%
2020-44.7%
2021-47.1%
2022-8.8%
2023+73.6%
2024-30.0%
2025+118.9%
2026+68.4%
2017 annual price return
+166.2%
2018 annual price return
+11.4%
2019 annual price return
-25.0%
2020 annual price return
-44.7%
2021 annual price return
-47.1%
2022 annual price return
-8.8%
2023 annual price return
+73.6%
2024 annual price return
-30.0%
2025 annual price return
+118.9%
2026 annual price return
+68.4%
LessMore
Alpha vs S&P 500
1Y+98.4%
3Y+23.2%
5Y+7.5%

Price returns only.

Download Historical Data

2,372 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

URGN Stock Price Trajectory (2017–2026)

As of October 10, 2026, UroGen Pharma Ltd. (URGN) trades at $36.83, representing a +113.4% return over the past year. The stock has delivered a +132.9% total return over five years (+18.4% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $69.57 on May 21, 2018. From this peak, URGN has corrected -47.1%, currently trading 21% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers PCVX (+59.6% 1Y), SUPN (-12.2% 1Y), and PRGO (-33.0% 1Y), URGN has outperformed the peer group average. Compare URGN vs PCVX →

URGN Historical Price Data · from 2017

Rows 1–50 of 2,372
Date Open High Low Close Volume Change %
2026-10-0936.9738.1036.7736.833.90M-0.41%
2026-10-0839.9240.0534.1836.982.02M-9.14%
2026-10-0740.9641.9340.6440.70477K-1.76%
2026-10-0643.2443.9941.0941.43761K-3.16%
2026-10-0541.3842.9140.5042.781.27M+3.33%
2026-10-0240.9341.8240.0941.40598K+2.10%
2026-10-0140.6341.2640.1140.55615K-0.20%
2026-09-3040.7241.0940.0940.63637K+0.44%
2026-09-2940.5041.6939.7540.45638K-1.20%
2026-09-2840.7441.3340.3240.941.15M-0.99%
2026-09-2541.4741.7840.6541.35647K+0.29%
2026-09-2441.3341.6240.0141.231.07M-0.96%
2026-09-2342.7242.7239.7241.631.28M-2.64%
2026-09-2243.5844.0042.6342.76387K-1.02%
2026-09-2143.3843.8442.9643.20475K-0.12%
2026-09-1843.7344.2543.1643.25616K-1.59%
2026-09-1744.8945.3343.1543.95681K+1.06%
2026-09-1642.0743.7242.0743.49994K+4.19%
2026-09-1543.2543.2541.1041.74537K-2.11%
2026-09-1442.3643.7242.0642.64506K+0.78%
2026-09-1143.6143.6141.6742.31675K+0.17%
2026-09-1044.2544.4841.8542.24686K-6.13%
2026-09-0943.9847.0043.9845.001.02M+2.70%
2026-09-0842.8044.7242.5043.81418K-0.62%
2026-09-0444.5445.0743.5544.09340K-1.76%
2026-09-0344.3745.6343.4544.88445K+1.04%
2026-09-0244.0145.8843.4944.42473K+2.37%
2026-09-0142.5943.5542.5443.39584K+0.70%
2026-08-3143.2344.8642.1343.09746K-1.22%
2026-08-2845.0945.5343.3943.62580K-4.13%
2026-08-2746.1346.5145.2845.50560K-0.96%
2026-08-2646.0046.6445.3645.94620K-0.91%
2026-08-2546.6547.1745.6746.36570K+0.43%
2026-08-2446.5247.0545.2746.16850K-1.49%
2026-08-2147.1347.2845.6046.86756K+0.13%
2026-08-2049.7149.7146.2046.801.12M-6.94%
2026-08-1949.8950.8148.5550.292.39M+2.80%
2026-08-1848.9349.5648.4148.92824K-0.45%
2026-08-1748.5149.5148.1649.141.30M+1.91%
2026-08-1447.6848.4846.6248.22458K+0.21%
2026-08-1349.6049.6047.6748.12860K-1.80%
2026-08-1247.4949.6747.1249.001.58M+4.01%
2026-08-1145.6147.3345.5247.11877K+1.73%
2026-08-1046.7446.8945.3446.31645K-1.38%
2026-08-0747.2348.1945.7546.961.03M+2.98%
2026-08-0646.1448.0345.5145.601.22M-1.79%
2026-08-0542.1747.8440.4146.432.48M+16.31%
2026-08-0439.2940.4638.8139.92735K+3.45%
2026-08-0337.7139.4136.6838.59965K+0.92%
2026-07-3141.1041.1138.0138.24815K-6.94%
…
Consensus & Technical Research Suite
Open URGN Terminal

URGN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

URGN — Frequently Asked Questions

Quick answers to the most common questions about buying URGN stock.

How has URGN stock performed recently?

URGN returned +113.4% over the past year, beating its 5-year annualized CAGR of +18.4%. The stock trades above its 200-day moving average, confirming the uptrend.

What is URGN's all-time high price?

UroGen Pharma Ltd. reached $69.57 on 2018-05-21. The 52-week high is $50.81. Current 1-year return of +113.4% places the stock closer to historical peaks.

Where can I download URGN historical price data?

This page provides URGN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2017-2026, downloadable in CSV format.

476 data points · sampled from 2,372